Eton Pharmaceuticals

1. Amglidia NDA filing2026Amglidia NDA filing, 2026, notable
2. Undisclosed ultra-rare disease generic FDAMid-2026Undisclosed ultra-rare disease generic FDA, Mid-2026, material
3. ET-700 extended-release zinc readoutmid-2026ET-700 extended-release zinc readout, mid-2026, notable
4. INCRELEX trial start2H 2026INCRELEX trial start, 2H 2026, routine
5. IMPAVIDO corporate updateSep 26, 2026IMPAVIDO corporate update, Sep 26, 2026, routine
6. ZENEO hydrocortisone autoinjector NDA filing2027ZENEO hydrocortisone autoinjector NDA filing, 2027, notable
7. ET-700 extended-release zinc NDA filing2027ET-700 extended-release zinc NDA filing, 2027, notable
8. ET-700 extended-release zinc trial startEarly 2027ET-700 extended-release zinc trial start, Early 2027, routine
9. ASN-001 NDA filing2H 2027ASN-001 NDA filing, 2H 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.